Cargando…

It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?

Detalles Bibliográficos
Autores principales:	Caiola, Elisa, Broggini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692659/ https://www.ncbi.nlm.nih.gov/pubmed/33139593 http://dx.doi.org/10.3390/cancers12113223

Ejemplares similares

Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
por: Iezzi, Alice, et al.
Publicado: (2018)

Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS
por: Caiola, Elisa, et al.
Publicado: (2016)

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo
por: Brunelli, Laura, et al.
Publicado: (2016)

The absorber that got too hot
Publicado: (1982)

How greedy is too greedy? A network toy model for evaluating the sustainability of biased evolutionary dynamics
por: Weinberger, V. P., et al.
Publicado: (2024)

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
por: Caiola, Elisa, et al.
Publicado: (2020)

LKB1: Can We Target an Hidden Target? Focus on NSCLC
por: Ndembe, Gloriana, et al.
Publicado: (2022)

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
por: Caiola, Elisa, et al.
Publicado: (2018)

How the zebra got its stripes: a problem with too many solutions
por: Larison, Brenda, et al.
Publicado: (2015)

Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX()
por: Iezzi, Alice, et al.
Publicado: (2016)

Greedy Approximation
por: Temlyakov, Vladimir
Publicado: (2011)

“If you got a problem, I got a problem too”: working toward making academic science more equitable
por: Bhalla, Needhi
Publicado: (2022)

It’s not too late
por: Topol, Eric
Publicado: (2022)

How hemp got high
por: Attar, Naomi
Publicado: (2011)

The ten roads to riches: the ways the wealthy got there (and how you can too!)
por: Fisher, Kenneth L, et al.
Publicado: (2009)

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells
por: Caiola, Elisa, et al.
Publicado: (2015)

NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2)
por: Colombo, Marika, et al.
Publicado: (2022)

Beware greedy algorithms
por: Simmons, Benno I., et al.
Publicado: (2019)

Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
por: Brunelli, Laura, et al.
Publicado: (2014)

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations
por: Colombo, Marika, et al.
Publicado: (2020)

Cancer genomics just got personal
por: Marszalek, Rafal T
Publicado: (2014)

New data: new options for front-line therapy in NSCLC?
por: Reinmuth, Niels
Publicado: (2018)

The Hookworm Blues: We Still Got ‘em
por: Sanders, John W., et al.
Publicado: (2017)

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
por: Grenda, Anna, et al.
Publicado: (2022)

A Year-Book of Therapeutics, Pharmacy and Allied Sciences
Publicado: (1872)

Genetics just got SEXY: Sequences encoding XY
por: Sleator, Roy D
Publicado: (2014)

Preconception care: it’s never too early
por: Mumford, Sunni L, et al.
Publicado: (2014)

Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach
por: Caiola, Elisa, et al.
Publicado: (2018)

COVID-19: too little, too late?
por: The Lancet
Publicado: (2020)

Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells
por: Sabatino, Maria Antonietta, et al.
Publicado: (2010)

Bacterial Encroachment in Metabolic Syndrome: Too Much Togetherness?
por: Frey, Mark R.
Publicado: (2017)

On a greedy approach for genome scaffolding
por: Davot, Tom, et al.
Publicado: (2022)

Optimal Greedy Control in Reinforcement Learning
por: Gorobtsov, Alexander, et al.
Publicado: (2022)

Sprue and Allied Disorders
Publicado: (1908)

An Allied Medical Organization
Publicado: (1919)

Spotlight on GOT2 in Cancer Metabolism
por: Kerk, Samuel A, et al.
Publicado: (2023)

Medical Men in India: Too Few or Too Many
Publicado: (1947)

SBRT for centrally localized NSCLC – What is too central?
por: Roesch, J., et al.
Publicado: (2016)

On Becoming an Ally
por: Epworth, Josh
Publicado: (2021)

Chiropractic care for children: too much, too little or not enough?
por: French, Simon D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h6smp1pnlcaolq3hfabs4jnd8v